Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions
Gespeichert in:
| Veröffentlicht in: | Oncogene 2024-04, Vol.43 (17), p.1317-1317 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1317 |
|---|---|
| container_issue | 17 |
| container_start_page | 1317 |
| container_title | Oncogene |
| container_volume | 43 |
| creator | Pradeep, C. -R Zeisel, A. Köstler, W. J. Lauriola, M. Jacob-Hirsch, J. Haibe-Kains, B. Amariglio, N. Ben-Chetrit, N. Emde, A. Solomonov, I. Neufeld, G. Piccart, M. Sagi, I. Sotiriou, C. Rechavi, G. Domany, E. Desmedt, C. Yarden, Y. |
| description | |
| doi_str_mv | 10.1038/s41388-024-02990-w |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2933464704</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3043529400</sourcerecordid><originalsourceid>FETCH-LOGICAL-c215w-8e096a834cc9628bd5177c7257252f31d7f929565040d1efa83234b711532aab3</originalsourceid><addsrcrecordid>eNp9kU2LFDEQhoMo7uzqH_AgAS9eWitf3Z29ybDuCiuC6Dmk09VtLz1Jm-rZwX9vxlkVPAgJdainnip4GXsh4I0A1b4lLVTbViB1-dZCdXjENkI3dWWM1Y_ZBqyBykolz9g50R0ANBbkU3amWi1ao-sNW7cpZwzrlOIl_5h6nKc48inee5rukXcZPa08-BgwX_Ixp8P6jQ8-rCkTX3JacD6WMSNRcfA08Jurz7JaEk3r0bBk3Pl5GqOPK5_xCNEz9mTwM-Hzh3rBvr6_-rK9qW4_XX_YvrutghTmULUItvat0iHYWrZdb0TThEaa8uSgRN8MVlpTG9DQCxwKKpXuGiGMkt536oK9PnnLhd_3SKvbTRRwnn3EtCcnrVK61g3ogr76B71L-xzLdU6VtpFWAxRKnqiQE1HGwS152vn8wwlwx0zcKRNXMnG_MnGHMvTyQb3vdtj_GfkdQgHUCaDSiiPmv7v_o_0J0WiYFQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3043529400</pqid></control><display><type>article</type><title>Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions</title><source>Springer Nature - Complete Springer Journals</source><creator>Pradeep, C. -R ; Zeisel, A. ; Köstler, W. J. ; Lauriola, M. ; Jacob-Hirsch, J. ; Haibe-Kains, B. ; Amariglio, N. ; Ben-Chetrit, N. ; Emde, A. ; Solomonov, I. ; Neufeld, G. ; Piccart, M. ; Sagi, I. ; Sotiriou, C. ; Rechavi, G. ; Domany, E. ; Desmedt, C. ; Yarden, Y.</creator><creatorcontrib>Pradeep, C. -R ; Zeisel, A. ; Köstler, W. J. ; Lauriola, M. ; Jacob-Hirsch, J. ; Haibe-Kains, B. ; Amariglio, N. ; Ben-Chetrit, N. ; Emde, A. ; Solomonov, I. ; Neufeld, G. ; Piccart, M. ; Sagi, I. ; Sotiriou, C. ; Rechavi, G. ; Domany, E. ; Desmedt, C. ; Yarden, Y.</creatorcontrib><identifier>ISSN: 0950-9232</identifier><identifier>EISSN: 1476-5594</identifier><identifier>DOI: 10.1038/s41388-024-02990-w</identifier><identifier>PMID: 38418546</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>Apoptosis ; Cell Biology ; Correction ; Human Genetics ; Internal Medicine ; Medicine ; Medicine & Public Health ; Oncology</subject><ispartof>Oncogene, 2024-04, Vol.43 (17), p.1317-1317</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Limited 2024</rights><rights>The Author(s), under exclusive licence to Springer Nature Limited 2024.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/s41388-024-02990-w$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/s41388-024-02990-w$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38418546$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pradeep, C. -R</creatorcontrib><creatorcontrib>Zeisel, A.</creatorcontrib><creatorcontrib>Köstler, W. J.</creatorcontrib><creatorcontrib>Lauriola, M.</creatorcontrib><creatorcontrib>Jacob-Hirsch, J.</creatorcontrib><creatorcontrib>Haibe-Kains, B.</creatorcontrib><creatorcontrib>Amariglio, N.</creatorcontrib><creatorcontrib>Ben-Chetrit, N.</creatorcontrib><creatorcontrib>Emde, A.</creatorcontrib><creatorcontrib>Solomonov, I.</creatorcontrib><creatorcontrib>Neufeld, G.</creatorcontrib><creatorcontrib>Piccart, M.</creatorcontrib><creatorcontrib>Sagi, I.</creatorcontrib><creatorcontrib>Sotiriou, C.</creatorcontrib><creatorcontrib>Rechavi, G.</creatorcontrib><creatorcontrib>Domany, E.</creatorcontrib><creatorcontrib>Desmedt, C.</creatorcontrib><creatorcontrib>Yarden, Y.</creatorcontrib><title>Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions</title><title>Oncogene</title><addtitle>Oncogene</addtitle><addtitle>Oncogene</addtitle><subject>Apoptosis</subject><subject>Cell Biology</subject><subject>Correction</subject><subject>Human Genetics</subject><subject>Internal Medicine</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Oncology</subject><issn>0950-9232</issn><issn>1476-5594</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kU2LFDEQhoMo7uzqH_AgAS9eWitf3Z29ybDuCiuC6Dmk09VtLz1Jm-rZwX9vxlkVPAgJdainnip4GXsh4I0A1b4lLVTbViB1-dZCdXjENkI3dWWM1Y_ZBqyBykolz9g50R0ANBbkU3amWi1ao-sNW7cpZwzrlOIl_5h6nKc48inee5rukXcZPa08-BgwX_Ixp8P6jQ8-rCkTX3JacD6WMSNRcfA08Jurz7JaEk3r0bBk3Pl5GqOPK5_xCNEz9mTwM-Hzh3rBvr6_-rK9qW4_XX_YvrutghTmULUItvat0iHYWrZdb0TThEaa8uSgRN8MVlpTG9DQCxwKKpXuGiGMkt536oK9PnnLhd_3SKvbTRRwnn3EtCcnrVK61g3ogr76B71L-xzLdU6VtpFWAxRKnqiQE1HGwS152vn8wwlwx0zcKRNXMnG_MnGHMvTyQb3vdtj_GfkdQgHUCaDSiiPmv7v_o_0J0WiYFQ</recordid><startdate>202404</startdate><enddate>202404</enddate><creator>Pradeep, C. -R</creator><creator>Zeisel, A.</creator><creator>Köstler, W. J.</creator><creator>Lauriola, M.</creator><creator>Jacob-Hirsch, J.</creator><creator>Haibe-Kains, B.</creator><creator>Amariglio, N.</creator><creator>Ben-Chetrit, N.</creator><creator>Emde, A.</creator><creator>Solomonov, I.</creator><creator>Neufeld, G.</creator><creator>Piccart, M.</creator><creator>Sagi, I.</creator><creator>Sotiriou, C.</creator><creator>Rechavi, G.</creator><creator>Domany, E.</creator><creator>Desmedt, C.</creator><creator>Yarden, Y.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>202404</creationdate><title>Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions</title><author>Pradeep, C. -R ; Zeisel, A. ; Köstler, W. J. ; Lauriola, M. ; Jacob-Hirsch, J. ; Haibe-Kains, B. ; Amariglio, N. ; Ben-Chetrit, N. ; Emde, A. ; Solomonov, I. ; Neufeld, G. ; Piccart, M. ; Sagi, I. ; Sotiriou, C. ; Rechavi, G. ; Domany, E. ; Desmedt, C. ; Yarden, Y.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c215w-8e096a834cc9628bd5177c7257252f31d7f929565040d1efa83234b711532aab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Apoptosis</topic><topic>Cell Biology</topic><topic>Correction</topic><topic>Human Genetics</topic><topic>Internal Medicine</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Oncology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pradeep, C. -R</creatorcontrib><creatorcontrib>Zeisel, A.</creatorcontrib><creatorcontrib>Köstler, W. J.</creatorcontrib><creatorcontrib>Lauriola, M.</creatorcontrib><creatorcontrib>Jacob-Hirsch, J.</creatorcontrib><creatorcontrib>Haibe-Kains, B.</creatorcontrib><creatorcontrib>Amariglio, N.</creatorcontrib><creatorcontrib>Ben-Chetrit, N.</creatorcontrib><creatorcontrib>Emde, A.</creatorcontrib><creatorcontrib>Solomonov, I.</creatorcontrib><creatorcontrib>Neufeld, G.</creatorcontrib><creatorcontrib>Piccart, M.</creatorcontrib><creatorcontrib>Sagi, I.</creatorcontrib><creatorcontrib>Sotiriou, C.</creatorcontrib><creatorcontrib>Rechavi, G.</creatorcontrib><creatorcontrib>Domany, E.</creatorcontrib><creatorcontrib>Desmedt, C.</creatorcontrib><creatorcontrib>Yarden, Y.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Oncogene</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pradeep, C. -R</au><au>Zeisel, A.</au><au>Köstler, W. J.</au><au>Lauriola, M.</au><au>Jacob-Hirsch, J.</au><au>Haibe-Kains, B.</au><au>Amariglio, N.</au><au>Ben-Chetrit, N.</au><au>Emde, A.</au><au>Solomonov, I.</au><au>Neufeld, G.</au><au>Piccart, M.</au><au>Sagi, I.</au><au>Sotiriou, C.</au><au>Rechavi, G.</au><au>Domany, E.</au><au>Desmedt, C.</au><au>Yarden, Y.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions</atitle><jtitle>Oncogene</jtitle><stitle>Oncogene</stitle><addtitle>Oncogene</addtitle><date>2024-04</date><risdate>2024</risdate><volume>43</volume><issue>17</issue><spage>1317</spage><epage>1317</epage><pages>1317-1317</pages><issn>0950-9232</issn><eissn>1476-5594</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>38418546</pmid><doi>10.1038/s41388-024-02990-w</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0950-9232 |
| ispartof | Oncogene, 2024-04, Vol.43 (17), p.1317-1317 |
| issn | 0950-9232 1476-5594 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2933464704 |
| source | Springer Nature - Complete Springer Journals |
| subjects | Apoptosis Cell Biology Correction Human Genetics Internal Medicine Medicine Medicine & Public Health Oncology |
| title | Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T03%3A09%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correction:%20Modeling%20invasive%20breast%20cancer:%20growth%20factors%20propel%20progression%20of%20HER2-positive%20premalignant%20lesions&rft.jtitle=Oncogene&rft.au=Pradeep,%20C.%20-R&rft.date=2024-04&rft.volume=43&rft.issue=17&rft.spage=1317&rft.epage=1317&rft.pages=1317-1317&rft.issn=0950-9232&rft.eissn=1476-5594&rft_id=info:doi/10.1038/s41388-024-02990-w&rft_dat=%3Cproquest_cross%3E3043529400%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3043529400&rft_id=info:pmid/38418546&rfr_iscdi=true |